SCHEMBL3230256

SCHEMBL3230256

NC(=O)CCCCCC(=O)N(c1ccc(F)cc1)c1ccccc1N

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 11/20 0.38
▸ HDAC1 Q13547 10/20 0.38
▸ HDAC2 Q92769 7/20 0.35
▸ NCOR2 Q9Y618 4/20 0.35
▸ HDAC10 Q969S8 4/20 0.35
▸ HDAC6 Q9UBN7 4/20 0.35
▸ HDAC4 P56524 3/20 0.35
▸ HDAC7 Q8WUI4 3/20 0.35
▸ HDAC11 Q96DB2 3/20 0.35
▸ HDAC8 Q9BY41 3/20 0.35
▸ HDAC9 Q9UKV0 3/20 0.35
▸ HDAC5 Q9UQL6 3/20 0.35
▸ ACHE P22303 1/20 0.34
▸ AGTR2 P50052 1/20 0.34
▸ LTB4R2 Q9NPC1 1/20 0.33
▸ MPO P05164 1/20 0.32
▸ S100A4 P26447 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16369620 0.89 ALDH1A1 (0.40) HDAC3HDAC1HDAC2NCOR2HDAC10
SCHEMBL3242812 0.89 ALDH1A1 (0.40) HDAC3HDAC1HDAC2NCOR2HDAC10
SCHEMBL3236511 0.87 HDAC3 (0.38) HDAC3HDAC1HDAC2NCOR2HDAC6
SCHEMBL2122406 0.87 HDAC1 (0.42) HDAC3HDAC1HDAC2NCOR2HDAC10
SCHEMBL1064934 0.86 HDAC3 (0.42) HDAC3HDAC1HDAC2NCOR2HDAC10
SCHEMBL3236989 0.85 HDAC1 (0.38) HDAC3HDAC1HDAC2HDAC10HDAC6
SCHEMBL3236466 0.85 HDAC1 (0.41) HDAC3HDAC1HDAC2HDAC10HDAC6
SCHEMBL3232050 0.80 HDAC3 (0.40) HDAC3HDAC1HDAC2NCOR2HDAC10
SCHEMBL3235377 0.80 HDAC3 (0.42) HDAC3HDAC1HDAC2NCOR2HDAC10
SCHEMBL3234061 0.80 HDAC3 (0.34) HDAC3HDAC1HDAC6MPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010028193-A1 COMPOUNDS INCLUDING PIMELIC ACID DERIVATIVES AS HDAC INHIBITORS REPLIGEN CORPORATION (US) 2010-03-11 — — WO disclosed
Send feedback